Rchr
J-GLOBAL ID:200901027209971759   Update date: Oct. 25, 2021

Tomita Shuhei

トミタ シュウヘイ | Tomita Shuhei
Affiliation and department:
Other affiliations (1):
Homepage URL  (1): http://www.med.osaka-cu.ac.jp/departments/bunshi-pharmacology.shtml
Research field  (3): Immunology ,  Medical biochemistry ,  Pharmacology
Research keywords  (6): 低酸素生物学 ,  血管生物学 ,  腫瘍免疫学 ,  Immunology ,  Pharmacology ,  Biochemistry
Research theme for competitive and other funds  (4):
  • 酸素ホメオスタシスに関する制御機構の解明
  • 低酸素シグナル伝達機構の解明
  • Hypoxia Signaling Pathway
  • Molecular Mechanism of TCDD-induced thymic atrophy
Papers (52):
  • Hutami IR, Izawa T, Khurel-Ochir T, Sakamaki T, Iwasa A, Tomita S, Tanaka E. HIF-1α controls palatal wound healing by regulating macrophage motility via S1P/S1P1 signaling axis. Oral diseases. 2021
  • Goto Wataru, Kashiwagi Shinichiro, Asano Yuka, Takada Koji, Morisaki Tamami, Takahashi Katsuyuki, Fujita Hisakazu, Shibutani Masatsune, Amano Ryosuke, Takashima Tsutomu, et al. Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment. BMC CANCER. 2020. 20. 1. 1215
  • Takada Koji, Kashiwagi Shinichiro, Asano Yuka, Goto Wataru, Morisaki Tamami, Takahashi Katsuyuki, Shibutani Masatsune, Amano Ryosuke, Takashima Tsutomu, Tomita Shuhei, et al. Significance of age-associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan. ONCOLOGY LETTERS. 2020. 20. 5. 180
  • Asano Yuka, Kashiwagi Shinichiro, Goto Wataru, Takada Koji, Takahashi Katsuyuki, Shibutani Masatsune, Amano Ryosuke, Takashima Tsutomu, Tomita Shuhei, Hirakawa Kosei, et al. Predicting therapeutic efficacy of endocrine therapy for stage IV breast cancer by tumor-infiltrating lymphocytes. MOLECULAR AND CLINICAL ONCOLOGY. 2020. 13. 2. 195-202
  • Kihira Yoshitaka, Fujimura Yoshino, Tomita Shuhei, Tamaki Toshiaki, Sato Eiji. Hypoxia-inducible factor-1 alpha regulates Lipin1 differently in pre-adipocytes and mature adipocytes. MOLECULAR MEDICINE REPORTS. 2020. 22. 1. 559-565
more...
MISC (1):
  • 松永 慎司, 冨田 修平. 【低酸素応答シグナルを治療標的とする-PHD阻害薬の治療応用-】PHD阻害薬によるがん微小環境と腫瘍免疫への影響. (公社)日本薬理学会 日本薬理学雑誌. 2020. 155. 1. 35-39
Lectures and oral presentations  (206):
  • 血管による酸素運搬は加齢関連疾患の発症にどう関係するか? 低酸素シグナルのがん微小環境に及ぼす影響
    (日本抗加齢医学会総会プログラム・抄録集 2020)
  • 抗酸菌の膜小胞に対する宿主免疫応答についての分析(Analysis of the Host Immune Response against Mycobacterial Membrane Vesicles)
    (日本細菌学雑誌 2020)
  • 再発乳癌におけるRe-biopsyによる免疫微小環境変化の検証
    (大阪市医学会雑誌 2019)
  • 乳癌術前化学療法症例の長期予後におけるサブタイプ別評価の意義
    (大阪市医学会雑誌 2019)
  • 腎虚血再灌流障害における尿細管細胞アポトーシスに対するCHAC1の役割
    (日本薬学会年会要旨集 2019)
more...
Professional career (1):
  • MD, PhD (*Kagawa Medical University*)
Association Membership(s) (3):
日本分子生物学会 ,  日本生化学会 ,  日本薬理学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page